课题基金 / 基金详情

Developmental Clinical Studies - Phase 1 studies on an analogue of peptide YY as a treatment for obesity

Developmental Clinical Studies - Phase 1 studies on an analogue of peptide YY as a treatment for obesity
发育临床研究 - 肽 YY 类似物治疗肥胖的 1 期研究
批准号：
G1000474/1
负责人：
Stephen Bloom
金额：
$350.04万
依托单位：
Imperial College London
依托单位国家：
英国
项目类别：
Research Grant
财政年份：
2011
资助国家：
英国
项目状态：
已结题
起止时间：
2011 至 --
来源：
https://gtr.ukri.org/projects?ref=G1000474%2F1
关键词：
DevelopmentalClinicalStudiesPhasestudies

项目摘要

项目成果

Stephen Bloom的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
When humans eat, the bowels naturally secrete chemicals into the bloodstream which make people feel full and which stop eating. One of these chemicals is known as Peptide YY (PYY). We have previously shown that injections of human PYY reduce appetite and food intake. We have now developed a very similar chemical, Y242, as a treatment for obesity. Y242 has been tested in animals and has been shown to be safe, and to reduce their appetite. This study will test Y242 for its safety and tolerability in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Next generation Y analogue for treatment of obesity
  • 批准号：
    MR/L013088/1
  • 项目类别：
    Research Grant
  • 资助金额：
    $519.47万
  • 财政年份：
    2014
  • 负责人：
    Stephen Bloom
  • 依托单位：
    Imperial College London
Do gut hormones mediate the beneficial effects of Roux-en-Y bypass surgery?
  • 批准号：
    MR/K02115X/1
  • 项目类别：
    Research Grant
  • 资助金额：
    $327.22万
  • 财政年份：
    2013
  • 负责人：
    Stephen Bloom
  • 依托单位：
    Imperial College London
Developmental Clinical Studies - Curing Obesity with the 'Medical Bypass'
  • 批准号：
    MR/J010731/1
  • 项目类别：
    Research Grant
  • 资助金额：
    $378.22万
  • 财政年份：
    2013
  • 负责人：
    Stephen Bloom
  • 依托单位：
    Imperial College London
Treatment of obesity by long acting analogues of peptide YY (PYY)
  • 批准号：
    G0802390/1
  • 项目类别：
    Research Grant
  • 资助金额：
    $93.76万
  • 财政年份：
    2009
  • 负责人：
    Stephen Bloom
  • 依托单位：
    Imperial College London
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data